Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences

José David Casanova1, Josefa González Carrillo2,3,4, Jesús Martín Jiménez2,3

  • 1Departamento de Ingeniería y Tecnología de Computadores, Universidad de Murcia, Espinardo, 30100 Murcia, Spain.

Insights

Trabeculated myocardium (TM) constitutes about 25% of the left ventricle in hypertrophic cardiomyopathy (HCM) patients. Increased TM proportion is linked to female sex, non-obstructive patterns, and reduced contractility, potentially identifying patients at risk for systolic heart failure.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Cardiovascular Disease

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by increased myocardial mass.
  • The clinical significance of trabeculated myocardium (TM) in HCM remains unclear.
  • Quantifying TM is essential for understanding its role in HCM pathophysiology.

Purpose of the Study:

  • To measure left ventricular (LV) mass and the proportion of trabeculation in HCM patients.
  • To investigate the clinical implications of trabeculated myocardium (TM) in hypertrophic cardiomyopathy (HCM).
  • To analyze the association between TM proportion and clinical parameters in HCM.

Main Methods:

  • Cardiac magnetic resonance (CMR) studies were performed on 211 HCM patients.
  • Dedicated software automatically delineated LV trabecular and compacted myocardial borders.
  • Trabeculated myocardium percentage (TM%) was calculated and analyzed against clinical factors.

Main Results:

  • The mean TM% was 26.7% ± 6.4%, with significantly higher values in females (29.7% ± 7.2%) compared to males (25.6% ± 5.8%).
  • Patients with LVEF < 50% exhibited higher TM% (30.2% ± 6.0%) compared to those with LVEF ≥ 50% (26.6% ± 6.4%).
  • Female gender and neutral hypertrophy patterns were associated with increased TM%, while dynamic obstruction and maximal wall thickness were inversely associated.

Conclusions:

  • Approximately 25% of the myocardium in HCM patients is trabeculated and measurable via automated software.
  • Increased trabeculated myocardium proportion is observed in females, non-obstructive HCM, and patients with reduced contractility.
  • Trabeculated myocardium may serve as a marker to identify HCM patients at risk for systolic heart failure.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
220
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
220
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
502
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K